Alkaline Phosphatase Predicts Survival in Patients with Metastatic Neuroendocrine Tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Alkaline Phosphatase Predicts Survival in Patients with Metastatic Neuroendocrine Tumors

Published:2006-05 Issue:5 Volume:51 Page:877-884
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Clancy Thomas E.,Sengupta Tanya P.,Paulus Jessica,Ahmed Fawzia,Duh Mei-Sheng,Kulke Matthew H.

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10620-006-9345-4.pdf

Reference33 articles.

1. Yu F, Venzon DJ, Serrano J, et al.: Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long–standing Zollinger–Ellison syndrome. J Clin Oncol 17(2):615–630, 1999 (available at: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation& list_uids=10080607)

2. Clements D, Elias E: Regression of metastatic vipoma with somatostatin analogue SMS 201–995. Lancet 1(8433):874–875, 1985 (available at: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2858733 )

3. Frank M, Klose KJ, Wied M, Ishaque N, Schade-Brittinger C, Arnold R: Combination therapy with octreotide and alpha-interferon: effect on tumor growth in metastatic endocrine gastroenteropancreatic tumors. Am J Gastroenterol 94(5):1381–1387, 1999 (available at: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10235222 )

4. Arnold R, Neuhaus C, Benning R, et al.: Somatostatin analog sandostatin and inhibition of tumor growth in patients with metastatic endocrine gastroenteropancreatic tumors. World J Surg 17(4):511–518, 1993 (available at: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation& list_uids=8395752 )

5. Saltz L, Trochanowski B, Buckley M, et al.: Octreotide as an antineoplastic agent in the treatment of functional and nonfunctional neuroendocrine tumors. Cancer 72(1):244–248, 1993 (available at: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve& db=PubMed&dopt=Citation&list_uids=8389666 )

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-tumor-related prognostic factors for immunotherapy–chemotherapy or immunotherapy alone as first-line in advanced non-small cell lung cancer (NSCLC);Clinical and Experimental Medicine;2024-03-15

2. Novel ensemble feature selection techniques applied to high-grade gastroenteropancreatic neuroendocrine neoplasms for the prediction of survival;Computer Methods and Programs in Biomedicine;2024-02

3. Enhancing precision: A predictive model for ¹⁷⁷Lu-DOTATATE treatment response in neuroendocrine tumors using quantitative ⁶⁸Ga-DOTATATE PET and clinicopathological biomarkers;Theranostics;2024

4. Does gamma-glutamyltransferase correlate with liver tumor burden in neuroendocrine tumors?;Endocrine;2023-09-28

5. Characteristics and treatment results of patients with gastroenteropancreatic neuroendocrine tumors in a tertiary care centre;BMC Endocrine Disorders;2023-04-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3